Add To Watchlist
Share URL
About The Company
CEO
Mr. Kevin Ronald Sayer
Market Cap
53.47 Billion USD
Sector
Healthcare
Website
https://www.dexcom.comLast Update
2/22/2024, 12:00:00 PM
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally.
Read More
Overview
Value
3
Growth
59
Health
56
Management
80
Analyst Opinion
94
Total
58
All Scores Out Of 100
Best Features
- Earnings growth has improved recently
- Low risk of bankruptcy
- Liked by analysts
- Low preportion of income is paid as dividend
Risk Factors
- Overvalued on cashflow basis
- There is a history of diluting shareholders
- No margin of safety at their current market price
- Disliked by Twitter users
- Price-to-earnings ratio of 81.8 is higher than the market average (19.6x)
- Dividend could be at risk
Market Peers
DXCM
Key Figures
PE Ratio (TTM)
81.79
Margin Of Safety (DCF)
-85.53%
Revenue Growth (5 Year Average)
19.36%
Ratings Consensus
Strong Buy
Share Buybacks
-2.44%
Dividend Yeild (TTM)
0.00%
Valuation
Value Score
3
Desired Margin Of Safety
0%
▼
Tip: Set your desired Margin Of Safety
Free Cash Flow Type
Annual Cashflow Growth
0%
Discount Rate
0%
Buy Target: < 9.1 USD ✘
Current Price: 115.3 USD
How Does This Work?
Show Advanced Options
This calculator helps investors estimate the Intrinsic Value of a company based on the current value of future cash flows. To use the tool, simply input a desired Margin Of Safety, which is an additional discount applied to the present value of the expected future cash flows. The tool calculates the present value using a discount rate that reflects the risk and time value of money, and provides an estimated target price for the company based on the selected margin of safety. The calculator defaults to using 5 Year Free Cash Flow Growth % and a discount rate based on the US 10-year treasury bond coupon rate. Use our performance analyser to get a feel the impact this has on longterm investment returns and discover a margin of safety you are comfortable with. This can be a useful tool for investors looking to make informed decisions about whether to buy or sell shares of a particular company.
Price/Earnings
81.79x
Free Cashflow Yeild
1.15%
PE/Earnings Growth
0.68
Price/Book
21.49x
Growth
Growth Score
59
- ✔ 5 Year Average Revenue growth of 19.36% is higher than the market average (10.97%)
- ✔ Revenue growth has improved this yeara
- ✔ Earnings growth has improved this year
- ✔ 5 Year Average Cashflow growth of 24.75% is higher than the market average (12.35%)
- ✔ Free Cashflow growth has improved this year
- ✘ 5 Year Average Earnings growth of 0.10% is lower than the market average (14.48%)
Revenue Growth
19.36%
Earnings Growth
0.10%
Cashflow Growth
24.75%
Health
Health Score
56
Altman Z Score
8.12
Piostroski Score
7.00
Debt/Equity
1.34x
Current Assets/Liabilities
1.99x
Free Cashflow/Total Debt
0.11x
Debt/Capital
0.78x
Dividend
Secure Dividend Score
0
- ✔ Long term dividend payout ratio of 0.00% is considered good
- ✔ Payout ratio (TTM) of 0.00% is lower than the average (40%)
- ✔ Dividends have shown growth over the last 5 years
- ✔ Spending a lower percentage of their income on dividends than last 5 years
- ✘ Dividend yeild of 0.00% is less than the market average (1.85%)
- ✘ Very unsafe
Dividend Yeild
0.00%
Dividend Growth
0.00%
Payout Ratio (Earnings)
0.00%
Payout Ratio (Cashflow)
0.00%
Management
Management Score
80
Average Buybacks/Dilution
-2.44%
Recent Buybacks/Dilution
-1.00%
5 Year Price Volitility
52.84%
Return On Assets
6.29%
Return On Capital Employed
9.97%
Return On Equity
15.91%
Return On Free Cashflow
N/A
Return On Investments
N/A
Analysts
Analyst Opinion
94
- ✔ Ratings consensus is Strong Buy
SEC Filings
Find yearly (10-K), quaterly (10-Q) and disclosure (8-K) report here, on the Securities and Exchange Commission's EDGAR database. If reading through reports isn't your cup of tea, don't worry. We've made it easy for you by summarizing all the important bits.
Other Information
Company Name
DexCom, Inc.
Currency
USD
Beta
1.154371
Vol Avg
2542047
Ceo
Mr. Kevin Ronald Sayer
Cik
0001093557
Cusip
252131107
Exchange
NASDAQ Global Select
Full Time Employees
7500
Industry
Medical Devices
Sector
Healthcare
Ipo Date
2005-04-14
Address
6340 Sequence Drive
City
San Diego
State
CA
Country
US
Zip
92121
Phone
858 200 0200
Analysis Last Updated
2/22/2024, 12:00:00 PM
All financial data provided by FMP
Social Sentiment
Social Sentiment Score
0
Twitter Sentiment
N/A
Stocktwits Sentiment
N/A